DOI : 10.1055/s-00000054

Pharmacopsychiatry

Issue 06 · Volume 21 · December 2011 DOI: 10.1055/s-002-22322


Abstracts of the IXth International Congress of the Interdisciplinary AGNP-TDM Task Force
Bolzano, 2nd–4th 9 2010

Alessandro Svettini, Bolzano; Maria Augusta Raggi, Bologna
Abstracts (HTML) List of Authors
A1
Hehl, R; Beck, S; Jahner, T; Melchner, D; Haen, E: A method for automated quantitative analysis of bupropion and its major metabolites in serum by high performance liquid chromatography (HPLC)
A2
Knoth, C; Vieth, A; Hiemke, C: Validation of four drug interaction programs for psychopharmacotherapy
A3
Klampfl, K; Fleischmann, Y; Wewetzer, Ch; Pfuhlmann, B; Mehler-Wex, C; Gerlach, M: Therapeutic drug monitoring (TDM) in children and adolescents during sertraline therapy
A4
Brandl, R; Köber, R; Jahner, T; Dörfelt, A; Haen, E: Enzyme assay to study the influence of citalopram on the concentration of psychotropic comedication
A5
Brünen, S; Sommerlad, D; Hiemke, C: Medication adherence determined by therapeutic drug monitoring in psychiatric outpatients with co-morbid substance abuse disorders
A6
Mercolini, L; Mandrioli, R; Gerra, G; Serpelloni, G; Raggi, MA: Original HPLC-F method for the simultaneous determination of cocaine and two metabolites in dried blood spots and plasma
A7
Saracino, MA; Bugamelli, F; Zanchini, S; Prugnoli, B; Raggi, MA: The use of dried blood spots as sample collection for the therapeutic drug monitoring of atypical antipsychotics
A8
Mercolini, L; Mandrioli, R; Ferranti, A; Amore, M; Raggi, MA: Therapeutic drug monitoring of the recent antidepressant duloxetine: method comparison
A9
Huber, E; Saria, A; Zernig, G: Does pharmacology explain dosing adjustments during antipsychotic combination therapy under naturalistic clinical conditions?
A10
Kruggel-Bachmann, S; Brünen, S; Hiemke, C; Mann, K: Improved therapeutic drug monitoring by intensified cooperation between physician and pharmacist
A11
Ostad Haji, E; Tadić, A; Dragicevic, A; Müller, MJ; Grasmäder, K; Rao, ML; Laux, G; Hiemke, C: Plasma concentrations of citalopram in inpatients with acute major depression are predictive for later non-response. Data from an observational study
A12
Merli, R; Haefele, E: Therapeutic drug monitoring use in clinical practice of a mental health service
A13
Lutz, UC; Hiemke, C; Wiatr, G; Farger, G; Arand, J; Wildgruber, D: Aripiprazole use during pregnancy and lactation
A14
Saracino, MA; Sammarco, A; Somaini, L; Gerra, G; Raggi, MA: Distribution of serotonin, 5-hydroxyindolacetic acid and homovanillic acid in biological fluids of psycotic patients treated with clozapine
A15
Onuoha, MR; Beck, S; Jahner, T; Melchner, D; Haen, E: Simultaneous serum determination of butyrophenones in automated column-switching high-performance liquid chromatography
A16
Raggi, MA; Mandrioli, R; Bugamelli, F; Mercolini, L; Saracino, MA; Marcheselli, C; Morganti, E: Plasma monitoring: a challenge for and of the laboratory
A17
Unterecker, S; Pfuhlmann, B; Hiemke, C; Greiner, C; Haen, E; Jabs, B; Kruggel-Bachmann, S; Deckert, J: Additive effects of sex, age and smoking on serum levels of venlafaxine and O-desmethylvenlafaxine under naturalistic conditions
A18
Hader, A; Beck, S; Jahner, T; Melchner, D; Haen, E: Identification of a slow CYP3A4 metabolizer by TDM – a case report
A19
Mandrioli, R; Mercolini, L; Ghedini, N; Amore, M; Kenndler, E; Raggi, MA: Comparison of CE and HPLC for therapeutic drug monitoring of the antiepileptic drug topiramate
A20
Wenzel-Seifert, K; Wittmann, M; Köstlbacher, A; Haen, E: Analysis of TDM data of clozapine: A daily consumption of less than 10 cigarettes is sufficient for maximum induction of clozapine metabolism
A21
Mercolini, L; Fulgenzi, G; Melis, M; Boncompagni, G; Albers, LJ; Raggi, MA: Therapeutic drug monitoring (TDM) of the recent antipsychotic ziprasidone in dried blood spots (DBS) and plasma
A22
Köstlbacher, A; Hiemke, C; Haen, E: Information search and software use in TDM laboratories – a survey